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Steady state ﬂuorescence de-quenching
Dynamic light scattering
FRET
Trophoblast syncytialisationStarD7 is a surface active protein, structurally related with the START lipid transport family. So, the present
work was aimed at elucidating a potential mechanism of action for StarD7 that could be related to its inter-
action with a lipid–membrane interface. We applied an assay based on the ﬂuorescence de-quenching of BD-
HPC-labeled DMPC–DMPS 4:1 mol/mol SUVs (donor liposomes) induced by the dilution with non-labeled
DMPC–DMPS 4:1 mol/mol LUVs (acceptor liposomes). Recombinant StarD7 accelerated the dilution of BD-
HPC in a concentration-dependent manner. This result could have been explained by either a bilayer fusion
or monomeric transport of the labeled lipid between donor and acceptor liposomes. Further experiments
(ﬂuorescence energy transfer between DPH-HPC/BD-HPC, liposome size distribution analysis by dynamic
light scattering, and the multinuclear giant cell formation induced by recombinant StarD7) strongly indicated
that bilayer fusion was the mechanism responsible for the StarD7-induced lipid dilution. The efﬁciency of
lipid dilution was dependent on StarD7 electrostatic interactions with the lipid–water interface, as shown
by the pH- and salt-induced modulation. Moreover, this process was favored by phosphatidylethanolamine
which is known to stabilize non-lamellar phases considered as intermediary in the fusion process. Altogether
these ﬁndings allow postulate StarD7 as a fusogenic protein.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Membrane fusion is a ubiquitous event in cell biology, and indeed
potentially all membranes can be merged under appropriate condi-
tions. Fusion is involved in processes such as fertilization, cell differ-
entiation (myoblasts and trophoblasts), transport of vesicles and
protein-mediated virus entry to host cells. Many effectors are in-
volved in the fusion process (e.g. intrinsic and extrinsic membrane
proteins [1]; calcium, in exocytosis [2]; hormones, growth factors
and antibodies, in receptor-mediated endocytosis [3]; pH, during
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cess, lipids are the ultimate actors in this phenomenon. There are
some lipids such as lysophosphatidylcholine, monoglycerides, phos-
phatidylethanolamine and phosphatidylserine that have been postu-
lated as fusogenic in model membranes because they play a key role
in membrane fusion [5]. However, it is unlikely that a particular lipid
can be fully responsible for fusion in natural cell membranes.
The transport of lipids and proteins between organelles is also an es-
sential process in the organization of different cellular compartments.
Phospholipids are predominantly synthesized in the endoplasmic reticu-
lum and subsequently transported to various destinations by vesicular
transport through the fusion of vesicles to an acceptor compartment or
can also be delivered to speciﬁc cellular organelles by monomeric ex-
change [6]. Several cytosolic proteinswith speciﬁc lipid binding domains
capable of accelerating lipid exchange in vitro have been identiﬁed.
Based upon the homology in the domain responsible for interacting
with the lipids, these proteins are grouped into six families called
CRAL/TRIO, PITP, ORP, GLTP, SCP and START [7]. Crystallographic studies
on theSTARTdomain of differentmembers of this superfamily show that
the three-dimensional organization of the domain forms a hydrophobic
tunnel which is wide enough to accommodate the lipid molecule [6,8,9].
StarD7 is a member of the START domain protein family. Recombi-
nant StarD7 protein is a surface active protein capable of interacting
with lipid monolayers, particularly with negatively charged phospho-
lipids such as phosphatidylserine and phosphatidylglycerol [10].
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mouse hepatoma cell line induced the increase in the intracellular
transport of exogenously incorporated phosphatidylcholine (PC) into
the mitochondria. Although it was suggested that StarD7 facilitated
the delivery of PC to mitochondria in non-vesicular form, the precise
mechanism by which PC was trafﬁcked remained to be elucidated
[11]. Moreover, there is an increase in StarD7 expression and partial
relocalization from the cytoplasm to the plasmamembrane during syn-
cytialisation, in vitro, of primary cytotrophoblasts from human placen-
tae [12]. Syncytialisation is a differentiation process, which involves
the intercellular fusion of trophoblast cells, concomitant with the trans-
location of phosphatidylserine from the inner to the outer leaﬂet of the
trophoblast plasma membranes [13]. To interpret these results there
might be two scenarios: a) StarD7 is involved in trophoblast differenti-
ation through the transport of phosphatidylserine through the START
domain [12] and/or b) StarD7 induces structural changes in the bilayer
phase leading to membrane fusion. Based on its structural homology
with other proteins of the START family, StarD7 might be postulated
as a lipid carrier protein. However, an effect of StarD7 on trophoblast
syncytialisation would support the protein has a fusogenic activity.
The presentworkwas aimed at elucidating themechanism of action
of StarD7 derived from its interactionwith a lipid–membrane interface.
2. Materials and methods
2.1. Materials
StarD7 (MW 34,697 Da), with a 95% purity as evidenced by SDS-
PAGE, was overexpressed in Escherichia coli and puriﬁed as described
previously [10]. The acyl chain labeled ﬂuorescent probes (Fig. 1)
DPH-HPC and BODIPY-FL-C5-HPC (BD-HPC) were purchased fromMo-
lecular Probes, Inc (Eugene, OR) and Avanti Polar lipids (Alabaster, AL),
respectively. DMPC,DMPE andDMPSwere purchased fromAvanti Polar
lipids (Alabaster, AL). Other chemicals were of analytical grade. Ultra-
puriﬁed water was used all through the experiments.
2.2. Fluorescence measurements
Fluorescence spectra were recorded with a Fluoromax Spex-3
Jovin Yvon (Horiba, NJ, USA) spectroﬂuorimeter equipped with aBODIPY-FL
DPH-H
Fig. 1. Chemical structures of ththermostatized cell, a Xe arc lamp and a photomultiplier tube as signal
detector, where light intensitywas registered by a photon counting sys-
tem. The excitation and emission slits were 2 nm wide. Emission spec-
tra were recorded between 500 nm and 600 nm at 490 nm excitation
wavelength.
2.3. Multilamellar vesicle (MLV) preparation
Lipidswere dissolved in chloroform/methanol (2:1 v/v). The solvent
was then evaporated under a streamon nitrogenwith constant rotation
of a test tube so as to deposit a uniform ﬁlm over the bottom third of a
tube and traces of solvent were removed under vacuum. The ﬁlm was
hydrated with 20 mM Tris–HCl, pH 7.8 by vortexing at a temperature
above the gel to liquid-crystalline phase transition temperature of the
lipids to obtain MLVs. The composition of “Donor” and “Acceptor” vesi-
cles and their relative proportions used in the present work was as
reported [14,15].
2.4. Donor liposomes
Small unilamellar vesicles (SUVs) were prepared essentially accord-
ing to Pereira-Lachataignerais and co-workers [16] using a high intensity
sonicator series Autotune, model 130W with a 3 mm-diameter titani-
um probe and at a high frequency of 20 kHz. Ten mL of MLV dispersion
containing 1:3.6 (mol/mol) mixture of BD-HPC (40 nM, ﬁnal concentra-
tion)with phospholipids (DMPC–DMPS 4:1mol/mol) was sonicated for
50 min (50 pulses with intervals of 15 s.) at 30W in a 15 mL tubemain-
tained on ice. Thus, labeled SUVs (SUVBD-HPC/PC/PS) were obtained and
used as donor liposomes. Non-labeled SUVs (SUVPC/PS) were also
prepared by applying the same procedure but in the absence of BD-
HPC. Samples were centrifuged at 10,000 rpm for 2 min in order to re-
lease titanium particles and maintained covered with aluminum foil to
prevent light incidence.
2.5. Acceptor liposomes
A MLVs' suspension containing 6 μM phospholipid concentration
(DMPC:DMPS 4:1) was extruded across polycarbonate 100 nm pore
size ﬁlters, according to MacDonald et al. [17] with a mini-extrusor-C5-HPC
PC
e ﬂuorescence probes used.
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vesicles (LUVs) obtained (LUVPC/PS) were used as acceptor liposomes.
2.6. Effect of environmental polarity on the spectroscopic behavior of
BD-HPC
BD-HPC was dispersed at 8 nM ﬁnal concentration in solvents that
differed in their polarity expressed by the value of their dielectric con-
stants (D) such as water (Dwater=78.36) and aqueous dioxane solutions
at 20, 45, 70 and 82% v/v dioxane concentrations (D20% dioxane=60.79;
D45% dioxane=38.48; D70% dioxane=17.69; D82% dioxane=9.53) [18]. Fluo-
rescence emission spectra were recorded between 500 and 600 nm.
BD-HPC has the dye (BODIPY FL) attached to the sn-2-acyl chain via
a C5 alkyl chain. BODIPY FL can form excimers at high concentrations
and unlike ﬂuorophores like pyrene, DPH and NBD, BODIPY FL has
been considered relatively environment insensitive and it is ﬂuorescent
in both aqueous and lipid environments [19,20]. However, our experi-
ments showed its sensitivity to medium polarity (see Fig. 3 below).
2.7. Fluorescence time course in the presence of StarD7 and LUVs
A suspension of “Donor” liposomes (SUVBD-HPC/PC/PS) was equili-
brated at room temperature (23 °C) in 20 mM Tris–HCl pH 7.8 buffer
(assay buffer). The effect of medium pH and ionic strength was eval-
uated using liposomes dispersed in 20 mM sodium acetate or 20 mM
sodium phosphate, pH 6 buffers, to check the anion effect, as well as
in 20 mM Tris–HCl, pH 7.8 buffer containing 500 mM NaCl. The resid-
ual ﬂuorescence intensity (FI) of the self-quenched probe ﬂuores-
cence was recorded for 10 min. Then, recombinant StarD7 protein
was added at the desired concentration and recording continued for
another 10 min until FI was stabilized. Finally, an excess of “Acceptor”
liposome suspension (LUVPC/PS) was added at a ﬁnal concentration of
6 μM.
2.8. Fluorescence resonance energy transfer assay —FRET
Two separated LUV samples containing either DPH-HPC or BD-HPC
(LUVDPH-PC/PC/PS and LUVBD-HPC/PC/PS, respectively) were prepared as de-
scribed above. Both samples were mixed together and the time-course
of the ﬂuorophore behavior was recorded at the BD-HPC emissionmax-
imum (λem=515 nm) after excitation at 356 nm (theλex of DPH-HPC),
in the absence and in the presence of StarD7.
2.9. Dynamic light scattering
Liposome size distribution was determined as described previously
by using a Nicomp™ 380 particle sizer (Nicomp Particle Sizer Systems,
Santa Bárbara, CA) operating at 532 nmand at an average count rate be-
tween 250 and 500 kHz; run timewas around 15 min formost samples.
Aliquots of vesicle suspension (1 mg of lipid per mL) with or without
StarD7 (35 μM) were taken for determinations. Measurements were
made at 22 °C. The time autocorrelation function of scattered light in-
tensities was analyzed by an inverse Laplace transform –ILS– algorithm
to obtain a volume weighted distribution of diameters [21].
2.10. Immunoﬂuorescence of BeWo cells
Morphological differentiation of BeWo cells (a trophoblast cell
line) treated with recombinant StarD7 protein was followed by im-
munoﬂuorescence microscopy to identify cell boundaries. Brieﬂy,
8000 cells/well were cultured in Ham's F12K on 96-well plates,
grown for 12 h and then incubated between 0 and 0.5 μM recombi-
nant StarD7 in phosphate buffered saline (PBS) for 20 h. After rinsing
with PBS, cells were ﬁxed 10 min in methanol at room temperature.
The cells were then rinsed with 0.2% Tween in PBS (PBST) three
times and then blocked in 10% normal goat serum (NGS) PBST. After10min, the cells were incubated at room temperature with the mouse
anti-desmosomal protein diluted in 10% NGS (ZK-31, 0.045 mg/mL,
Sigma-Aldrich Inc. St. Louis, MO, USA). After 1 h, the antibody solution
was removed, the cells were rinsed with PBST three times and then in-
cubated 1 h with the Alexa Fluor 488-conjugated goat anti-mouse IgG
(Molecular Probes, Inc., Eugene, OR) was applied. Cells were washed
with PBST three times and nuclei were counterstained with Hoechst
33258 dye. Finally, each well was rinsed and covered with PBS to ana-
lyse by microscopy (Eclipse Ti confocal microscope, Nikon).
Intercellular fusionwas quantiﬁed by counting the number of nuclei
in syncytia and the total number of nuclei in an average of ten micro-
scopic ﬁelds from each condition. The percentage of the nuclei in syncy-
tia was determined as: (number of nuclei in syncytia/total number of
nuclei)×100, as described [22]. Duplicate wells were evaluated in
each experiment, and each experiment was performed at least twice
independently.
2.11. Statistical analysis
Statistical analysis was performed using the GraphPad Prism 5.0
software. One-way analysis of variance (ANOVA) followed byDunnett's
Multiple Comparison post-Testwas applied and pb0.05was considered
statistically signiﬁcant.
3. Results
StarD7 induced a concentration-dependent increase in the FI emitted
by the BD-HPC incorporated in SUV donor vesicles (SUVBD-HPC/PC/PS)
(Fig. 2). Upon StarD7 addition (ﬁrst stage) at concentration≥2 nM FI in-
creased hyperbolically as a function of time up to a plateau (FImax1). At
concentrations ≤0.4 nM StarD7 did not cause any detectable effect. The
subsequent addition of a ﬁxed amount of non-labeled LUVPC/PS (second
stage) induced a further increase in FI also following a hyperbolic time-
course and ﬁnally reaching a second maximal intensity level (FImax2)
(Fig. 2a).
In Fig. 2b the values of FImax1 and FImax2, determined at both pla-
teaux,which appeared after the addition of StarD7 and LUVPC/PS, respec-
tively, were plotted as a function of the StarD7 concentration.
In the presence of StarD7 alone, FImax1 increased in a linear fashion
relative to the protein concentration. The maximum dequenching
achieved within the concentration range of StarD7 tested was 84.7%
however, in another experiment using 10 nM StarD7 (see Control
sample in Fig. 7b) a similar percentage of dequenching was reached.
From these results it could be concluded that the dequenching effect
cannot be completed with the sole effect of StarD7. Thus, the effect of
StarD7 possibly was due to a hydrophobic environment provided by
the protein to the ﬂuorescent probe. Moreover, 100% dequenching
cannot be reached due to the fact that some labeled molecules, locat-
ed in the inner membrane leaﬂet, are not accessible to the protein.
This possibility was tested by a spectroscopic analysis of the probe
in media of different polarities (see below).
In contrast to the linear behavior of FImax1, FImax2 measured in the
presence of LUVPC/PS followed a biphasic trend with a discontinuity at
≅0.4 nM StarD7. Below this concentration the slope was steeper than
in the absence of acceptor LUVs and at higher StarD7 concentrations
the slope was less steep, suggesting a tendency towards saturation.
The spectra of BD-HPC emission ﬂuorescence, depicted in Fig. 3a,
exhibited a red-shift and a signiﬁcant decrease in ﬂuorescence inten-
sity (quenching) as the medium became more polar (higher D). This
behavior was observed within the whole range of D values examined
and the stronger effect appeared as D increased from 60 to 80 (80 to
100% water) (Fig. 3b).
Evaluation of possible effects of lipid–protein binding on the
dequenching efﬁciency of StarD7 is shown in Fig. 4. The dequenching
effect observed at pH 7.8 after the addition of LUVs was stronger in
Tris–HCl buffer (Fig. 4a) compared to phosphate buffer (Fig. 4b). It
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Fig. 2. StarD7 favors BD-HPC ﬂuorescence dequenching. Fluorescence intensity of
BD-HPC in DMPC–DMPS mixed SUV (SUVBD-HPC/PC/PS) was measured as a function of
StarD7 concentration. (a) Additions of StarD7 (thick arrow) and LUVs (thin arrow)
are indicated. Numbers in the ﬁgure refer to StarD7 concentrations. (λex=490 nm
and λem=515 nm).(b) Fluorescence intensity at the plateaus: at 1000 s (▽) (after
the addition of StarD7) and at 2250 s (●) (after the addition of StarD7 plus LUVs). In
the text they were referred to as FImax1 and FImax2, respectively.
λ  (nm)














































































Fig. 3. Effect of medium polarity of the ﬂuorescence emission of BD-HPC. (a) Fluores-
cence emission spectra were recorded at an excitation wavelength λex=490 nm. BD-
HPC was dissolved in aqueous media containing dioxane at the concentration indicated
by the numbers expressed in % v/v units. (b) Fluorescence intensity at λem=515 nm
(●) taken from spectra in panel (a) as a function of the dielectric constant (D) of the
solvent (bottom x axis) or % v/v water (upper x axis).
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of Tris–HCl and phosphate buffers were approximately 40 mosM and
80 mosM, respectively. The rise in the ionic strength caused by adding
500 mM NaCl leads to a total inhibition of the effect of LUVs on FI
(Fmax2 ≅0) (Fig. 4c). In Tris–HCl buffer pH 7.8 with StarD7 protein
at 10 nM, the dequenching in the second stage (FImax2) was slightly
lower than in the absence of StarD7 (Fig. 4c, compare full and dotted
lines). In contrast, no difference was observed when using phosphate
buffer. At pH 6, close to the isoelectric point of StarD7, independent of
the buffer used, acetate (Fig. 4d) or phosphate (Fig. 4e), the addition
of StarD7 enhanced both Fmax1 and Fmax2, but the ﬁnal FImax2 levels
reachedwere lower than at pH 7.8 (lower lipid–protein electrostatic in-
teraction) and, as expected, Fmax2 was higher in the presence of StarD7
than in its absence.
A FRET experiment was used to evaluate whether lipid molecules
merged as an intermediary stage of the bilayers undergoing fusion. As
depicted in Fig. 5a, the emission spectrum of DPH-HPC (λex, DPH
HPC=356 nm; λem, DPH HPC=427 nm) overlapped the excitation spec-
trum of BD-HPC (λex, BD-HPC=490 nm). This indicated that both probes
would behave as a good donor/acceptor FRET couple. The high quantum
yield ofﬂuorescence, high efﬁciency of FRET (Ro is estimated to be 60 Å),
photostability, and localization in the central hydrophobic region of a bi-
layer all make this pair of probes quite appropriate for detecting fusion.
In this experiment, at the starting point, there was a mixture of two
populations of LUVs labeled either with DPH-HPC or BD-HPC, and the
excitation wavelength was that of DPH-HPC (λex,DPH-HPC=356 nm).
Fig. 5b shows the emission spectra of the LUVsmixture at different time-
points (T1=3 min and T2=6 min). There was a decrease in 427 nm
(λem DPH-HPC) and an increase in 515 nm (λem,BD-HPC) vs time due toprobe mixing which favored Förster's energy transference from DPH-
HPC (λex=356 nm) to BD-HPC (λem=515). A time-course of the ﬂuo-
rescence intensity ratio between FI at theλem of DPH-HPC (427 nm) and
FI of BD-HPC (515 nm) (FI427/515) was then calculated (Fig. 5c). For this,
a decrease in FI427/515 was taken as an indication of FRET. Only samples
containing StarD7 exhibited the decrease in FI427/515 demonstrating that
both probes, originally located in different bilayers, were able to come
within the Förster's distance.
Upon bilayer fusion we anticipated ﬁnding larger particles. The
measurement of the liposome size, used in the lipid dilution assay,
obtained by DLS conﬁrmed the mean particle size expected for SUVs
(33 nm) and LUVs (107 nm) (Table 1). We also intended to measure
the size of StarD7 molecules. However, this required the use of solu-
tions at very high protein concentrations (35 μM) which lead to pro-
tein self-aggregation as shown by the size (547 nm) of the particles
detected. It is expected that protein aggregation would not have oc-
curred in the membrane fusion experiments (performed at 10 nM
StarD7) because soluble protein monomers would be undetectable
(4.39 nmdiameter estimated from values of average density of proteins
(δ=1.3 g/cm3) and the molecular weight of StarD7 (MW=34,697))
[23]. The addition of StarD7 to SUV samples induced the appearance
of particles of 41 nm diameter whichmay result from SUV fusion (Pop-
ulation I, Table 1). Two peaks were observed after the addition of LUVs
to SUV samples, one of them more abundant (87%) of 48 nm diameter,
possibly resulting from SUV–SUV fusion (Population I), and another
population (II, 13% abundance) whichmight represent a complex com-
bination of several particles, including SUVs which are more unstable
compared to LUVs (see Discussion).
To evaluate the occurrence of interior mixing as the latter stage of a
complete fusion process, BeWo cells were cultivated with recombinant
Time (s)
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Fig. 4. Role of electrostatic interactions on the StarD7-induced BD-HPC ﬂuorescence dequenching. The effect of pH and ionic strength of the medium on the temporal change of BD-HPC
ﬂuorescence intensity is depicted. Experiments were performed in the presence (dotted line) or in the absence (solid line) of 10 nM StarD7. Addition of StarD7 (thick arrow) and LUVs
(thin arrow) is indicated. Fluorescencewas recorded atλex=490 nmandλem=515 nm. Solvents used for protein solution and vesicle dispersion preparationswere: (a) 20 mMTris–HCl
pH 7.8 buffer; (b) 20 mM phosphate pH 7.8 buffer; (c) NaCl 500 mM in 20 mM Tris–HCl pH 7.8 buffer; (d) 20 mM acetate pH 6 buffer and (e) 20 mM phosphate pH6 buffer.
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reduction in desmoplakin protein by ﬂuorescence microscopy. As
shown in Fig. 6b, the presence of 0.5 μM StarD7 protein induced the
formation of multinucleated giant cells. All the concentrations assayed
exhibited an increase statistically signiﬁcant with respect to the control
(Fig. 6c).
The effect of a fusogenic lipid on the StarD7-induced dequenching
efﬁciency was also tested. Similar experiments were performed to
those shown above (Fig. 2). At ﬁrst step, the FI changes were registered
after adding either SUVPE-PS, SUVPC-PS or buffer (control) alone (Fig. 7a)
or simultaneously with StarD7 (Fig. 7b). In the absence of StarD7
(Fig. 7a), the addition of either SUVPE-PS or SUVPC-PS to SUVBD-HPC/PC-PS
induced a hyperbolic dequenching of BD-HPC ﬂuorescence being
SUVPE-PS the most effective. The subsequent addition of non-labeled
LUVPC-PS exerted a further increase in all samples up to a similar maxi-
mum level after prolonged incubation, supporting a saturating effect.
The data in Fig. 7b demonstrate that StarD7 potentiated the dequench-
ing effect of SUVPC-PS if it is compared to control experiments in the ab-
sence of StarD7 (Fig. 7a). The subsequent addition of LUVPC-PSleads all
samples to the same maximum of ﬂuorescence. However, when
SUVPE-PS were added in the ﬁrst stage, the subsequent addition of
LUVPC-PS in the second stage exhibited only a slight additional increase
in FI reaching the same maximum with no additional increase. In the
presence of PE the dequenching effect was already at a maximum
level in the absence of StarD7. Thus, these results suggested that both
the fusogenic PE and StarD7 exerted their dequenching effects throughthe same mechanism (i.e. membrane fusion). Net changes determined
after each stage are synthesized in Fig. 7c. There, it is shown that the
presence of PE is highly effective in inducing liposome fusion per-se. It
is also noticeable that the stronger the effect in the ﬁrst stage, the
lower is the increment in the second stage. These ﬁndings reinforce
the concept of a saturating effect in the system, underscoring the poten-
tiating effect of StarD7 on membrane fusion, mainly observed in the
other two samples (StarD7 alone and StarD7 plus SUVPC-PS).
4. Discussion
In the present report we propose a function and a mechanism of
action for StarD7, a protein structurally related with a protein family
involved in lipid transfer processes. In doing so, we applied an experi-
mental procedure widely considered useful to demonstrate lipid trans-
fer from SUVs to LUVs [15]. However, considering the results from a
biophysical perspective leads us to suspect the possibility that this phe-
nomenon involves lipid dilution through a bilayer fusion. Thus, once the
StarD7-induced ﬂuorescence dequenching was demonstrated (Fig. 2)
the experiments that followed aimed to show that membrane fusion
is a possible mechanism explaining this result.
4.1. StarD7 stimulates BD-HPC ﬂuorescence dequenching
StarD7 exhibited a concentration-dependent ability to increase the
ﬂuorescence intensity quantum yield of the BD-HPC present in donor
Time (s)







































































Fig. 5. StarD7 induces lipidmixing. (a) Excitation (solid lines) and emission (dotted lines)
ﬂuorescence spectra of DPH-HPC (black) and BD-HPC (gray). (b) Emission spectra of DPH-
HPC (thick black line) and BD-HPC (thick gray line) alone in separate LUVs and at different
times (T1=3 min and T2=6 min) after LUVsmixing (thin lines). (c) FI427/515 corresponds
to the ﬂuorescence intensity ratio between FI at the λem of DPH-HPC (427 nm) and BD-
HPC (515 nm). A decrease in FI427/515 is an indication of FRET. At t0, samples contained a
mix of two different LUVs, one labeled with BD-HPC and the other one with DPH-HPC.
Arrow points to further addition of 10 nM StarD7 (gray lane) or buffer (black lane).
Table 1
Frequency distribution analysis of mean particle diameters assessed by dynamic light
scattering.
Sample Addition Mean particle diameter (nm)
Population I Population II
SUVPC/PS Buffer 33±3 (100) –
LUVPC/PS Buffer 107±1 (100) –
StarD7a (35 μM) Buffer 129±20 (91) 547±127 (9)
SUVPC/PS StarD7b 47±4 (94.4) 326±6 (5.6)
LUVPC/PS 48±4 (87) 202±5 (13)
StarD7b +LUVPC/PS 44±0.1 (93) 175±1.5 (7)
Numbers between brackets refer to weighted number frequency distribution.
a The high StarD7 concentration used in these experiments suggests that populations
observed may represent different types of protein aggregates.
b It is expected that protein aggregation would not have occurred in these experiments
because StarD7 concentration was signiﬁcantly lower (10 nM).
(b)(a)
[StarD7] (μM)























Fig. 6. StarD7 stimulates cell–cell fusion. Morphological differentiation of BeWo cells
cultivated in the presence (b) or not (a) of recombinant 0.5 μM StarD7 protein. Cells
were ﬁxed and immunostained with anti-desmoplakin (green) to identify boundaries.
Nuclei were stained with Hoechst dye. Arrows show syncytium-like structures. (a) As a
negative control the cells were incubated with the vehicle (PBS). (c) Percentage of nu-
clei in syncytia with respect to total number of nuclei at different StarD7 concentrations.
Results represent the mean±SEM of three independent experiments performed in du-
plicate. *Signiﬁcant difference (pb0.05) compared to the control condition.
430 S. Angeletti et al. / Biochimica et Biophysica Acta 1818 (2012) 425–433liposomes (SUVs) (Fmax1) and to accelerate, the dilution of labeled lipids
after the addition of acceptor liposomes (LUVs) (Fmax2) (Fig. 2). StarD7
potentiated lipid dilution following addition of LUVs even at concentra-
tions too low to cause an effect in the presence of SUVs alone ([StarD7]
≤0.4 nM) (Fig. 2a and b). These results lead us to propose the following
hypothesis: a) the linear behavior of FImax1, which is an effect of StarD7
alone, is due to the probe binding within hydrophobic environments
(protein pockets, protein aggregates or lipid–protein interfaces),
b): the discontinuous trend of FImax2 does not reveal themechanism in-
volved in the process but reﬂects a tendency toward the saturation of
the probe dilution effect suggesting the requirement of StarD7 binding
to the lipid–water interface and c) the latter result could be a conse-
quence of bilayer fusion, hemifusion, collapse of vesicle morphology,or monomeric lipid transfer. Thus this experiment alone cannot deﬁne
the mechanism by which lipid dilution occurs.4.2. Effect of the medium polarity on BD-HPC ﬂuorescence emission
intensity
The quenching of the ﬂuorescence intensity can be explained
through a reduction in the quantum yield of the ﬂuorophore due to
the fact that non-radiative relaxation routes became faster (more fa-
vorable) compared to ﬂuorescence. This phenomenon can be induced
by the stabilization of a charge transfer state as a result of strong local
electric ﬁelds near the ﬂuorophore due to probe–probe interactions
or imposed by water molecules interacting through H-bonds. It has
been demonstrated that microscopic H-bonding and not the bulk di-
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Fig. 7. Effect of the chemical composition of nonlabeled SUVs added on BD-HPC dequench-
ing. At time zero and up to 600 s, samples contained SUVBD-HPC/PC/PS. (a) Addition of nonla-
beled SUVPE-PS or SUVPC-PS and LUVPS-PCis indicated by the arrows. (b) Same as in (a) but
StarD7 was added alone or simultaneously with nonlabeled SUVs. In the control sample,
buffer (a) or StarD7 (b) was added. Fluorescence was recorded at λem=515 nm
(λex=490 nm). (c) ΔFI=FIt=1000−FIt=0 before (−LUVs) or ΔFI=FIt=1500−FIt=1000
or after (+LUVs) the addition of LUVs.
431S. Angeletti et al. / Biochimica et Biophysica Acta 1818 (2012) 425–433explain the decrease in the ﬂuorescence intensity of BD-HPC as its ac-
cessibility to water increases (e.g. at decreasing concentration of di-
oxane in aqueous solutions such as in Fig. 3).
Taking into account that BD-HPC is an acyl chain-labeled zwitterionic
probe, it is expected that in aqueous media, it is either self-assembled or
incorporated in a lipid self-assembled structure with the ﬂuorescent
moiety embedded within the hydrophobic core of the structure. In addi-
tion, the presence of large concentrations of BD-HPC would be expected
to impact negatively on its quantum yield through a self-quenching phe-
nomenon [25] which can be relieved upon dilution. Thus, in addition to
H-bonding and the stabilization of charge transfer state intermediate,
an increased tendency to self-assembling and consequently self-
quenchingwould have contributed to the steeper reduction in the quan-
tum yield as the water content of the solvent increased from 80 to 100%
v/v in Fig. 3b.
These results give experimental support to the hypothesis that the
increase in BD-HPC ﬂuorescence intensity (FImax1 in Fig. 2b) up on theaddition of StarD7 to the media containing SUVBD-HPC/PC/PS can be
explained by a binding of BD-HPC either within hydrophobic pockets
of StarD7, StarD7 aggregates, or lipid–StarD7 interfaces, which are
expected to be dehydrated environments. Thus, through the formation
of mixed lipid–protein self-assembled structures, StarD7 would be able
to offer a more hydrophobic environment with lower access to water
leading to an increase in the quantum yield and at the same time
might induce a small dilution-like effect relieving the self-quenching
of ﬂuorescence emission. Hence, a monomeric lipid–protein interaction
model is not necessary to explain these results.
4.3. Role of electrostatic interactions in the StarD7-induced BD-HPC
ﬂuorescence dequenching
Within the bulk pH range assayed the surface charge density of the
vesicles used remained negative and constant. Results shown in Fig. 4
(FImax1) suggest that electrostatic interactions seemed not to affect sig-
niﬁcantly the StarD7–SUVBD-HPC/PC/PS binding at 1:20 protein/lipid
molar ratio. Possibly, at this protein concentration, a high level of pro-
tein–lipid binding impaired bilayer fusion revealed by the small
changes induced by StarD7 in FImax2 values (Fig. 4a). This was partially
reversed by a binding partial inhibition induced by phenomena such as
buffer change (the osmolarity of Tris–HCl was lower than that of phos-
phate buffer) or a decrease in protein surface charge at pH 6. However,
when surface charges were screened in the presence of high salt con-
centration (Fig. 4c), only the stages that follow LUVPC-PS addition,
were blocked, and the self-quenching of BD-HPC ﬂuorescence was not
released. The participation of StarD7 in this stage depends on electro-
static interactions, as well as on its relative concentration with respect
to LUVs (1:600 protein/lipid molar ratio). (Notice that results shown
in Fig. 2 correspond to protein/lipid molar ratios that varied from
1:1500 to 1:30,000). From this experiment we conclude that a strong
inhibition of StarD7–lipid binding totally abolished the dequenching
and possible fusion (Fig. 4c).
4.4. Mechanism of dequenching of BD-HPC ﬂuorescence in the presence
of StarD7
An experimental setup similar to that used in the present work
has been applied under the assumption that it is the appropriate
one to test protein effectiveness as exchangers of lipid molecules in
amonomeric formbetween twomembranes [15]. However, membrane
fusion may also be a feasible mechanism to explain ﬂuorescence
dequenching through lipid dilution (Fmax2 in Fig. 2). To demonstrate
that a protein has fusogenic activity, three activities should be demon-
strated: a) lipid mixing, b) increase in vesicle size and c)mixing of inte-
rior aqueous contents [26,27]. All these conditions were examined to
test whether StarD7 had fusogenic potential.
4.4.1. StarD7 induced lipid mixing
Förster energy transfer (FRET) is a probabilistic event based on the
radiationless transfer of excitation energy from a donor to an acceptor.
FRET depends on the degree of spectral overlap of the donor and accep-
tor. Moreover, since the interaction between the donor and acceptor is a
dipole–dipole interaction, FRET is a distance- and orientation-dependent
interaction. The energy transfer occurs typically over a distance of
1–10 nm. Only samples containing StarD7 exhibited the decrease in
FI427/515 demonstrating that both probes, originally located in different
bilayers, approximated within the Förster's distance. This result indicat-
ed that in the presence of StarD7 one of the conditions for bilayer mem-
brane fusion, lipid mixing, occurred.
4.4.2. StarD7 promotes an increase in vesicle size
This conclusion is based on the fact that, as reported previously
[28], the area of vesicles formed by fusion should be equal to two
small vesicles. The resulting radius would be larger than the original
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than that of the original vesicle by a factor of 23/2 and the sum of
the two in 21/2. Then, the merging of two equal spherical vesicles
would result in an increase of 41% of the volume of two individual vesi-
cles. This rule was followed by the 33 nm SUVs, which after the addition
of StarD7 exhibited amean vesicle size of 47 nm (particle Population I in
Table 1). Moreover, another population of 326 nm particles, almost 10
times larger than the original SUVs was observed and these may be
explained by the presence of free- or lipid bound-protein aggregates.
However, these particles (Population II) represented only a 5.6% of the
total particle distribution.
The addition of LUVs to SUVs in the presence of StarD7 produced two
populations of vesicles. The more abundant population (87%) with a
mean diameter of 48 nm represents fusion between two SUVs (Popula-
tion I). The second less abundant population (II, 13% abundance) was
larger than expected from the fusion of two 107 nm diameter LUVs
which would be predicted to have been approximately 150 nm in diam-
eter. The Population II vesicles may represent a complex combination of
several particles, including SUVs which are less stable than LUVs.
Compared with SUVs–protein samples, in SUVs–protein–LUVs sam-
ples the lipid/protein ratio increased from 286 up to 571 mol/mol. In
these experiments, in addition to a smaller (44 nm) andmore abundant
(93%) population of particles, there was another population of 175 nm
diameter. These particles were smaller than those formed in mixtures
of SUV–LUV in the absence of StarD7 (202 nm), as well as being smaller
than protein aggregates in the absence of lipid (326 nm). This result
may be explained by the participation of a higher proportion of SUVs
being incorporated into particles in the presence of StarD7 and from
the inhibition of protein aggregation due to the higher availability of
lipid–water interfaces.
Taken together these results indicate that the SUV–SUV fusion, as
well as SUV–LUV fusion can be promoted by both StarD7 and LUVs
alone or in combination. The lower particle size of Population II obtained
following the addition of StarD7 and LUVs together may indicate the
higher proportion of SUVs in the composition of the fused particles,
and could explain the more efﬁcient probe dilution (higher ﬂuorescence
dequenching) observed in SUVs–protein–LUVs samples compared with
SUVs–LUVs (Fig. 2).
4.4.3. StarD7 facilitates mixing of aqueous interior (cell–cell fusion)
To test the third condition to demonstrate that StarD7 is a fuso-
genic protein, we studied cell–cell fusion by ﬂuorescence microscopy
[29]. Since we had determined a partial relocalization of this protein
to cytoplasmic membrane during trophoblast differentiation, we se-
lected the human trophoblastic cell line, BeWo, for this assay.
The presence of StarD7 protein induced the formation of multinuc-
lear giant cells (Fig. 6b). This process consists of the fusion of mononu-
clear undifferentiated cells to form differentiated syncytium-like cells
with the loss of intercellular boundaries resulting in the mixing of
their cytoplasmic contents at all the StarD7 concentrations tested
(Fig. 6c).
Taken together, FRET, DLS and cell–cell interaction experiments
allow us to conclude that the dequenching of BD-HPC induced by
StarD7 is mediated by a bilayer fusion as all the conditions required
to accept a fusogenic effect, i.e. lipid mixing (Fig. 5b), increase in ves-
icle size (Table 1) and mixing of interior aqueous contents (Fig. 6)
have been demonstrated.
4.5. The impact of fusogenic lipids on BD-HPC ﬂuorescence dequenching
induced by StarD7
Fusion is a process that involves the participation of intermediate
lipid structures (stalk structure) which resemble the well known
inverted phases (hexagonal II or cubic phases) [30]. The geometric
and thermodynamic conditions required to stabilize such phases can
be satisﬁed by phospholipids having small polar head group areacomparedwith the area occupied by two hydrocarbon chains. Phospha-
tidylethanolamine joins these properties and when it accompanies
other phospholipids in bilayers facilitates their fusion. It is known that
aqueous dispersions of unsaturated PE adopt the HII hexagonal struc-
ture, while other fusogenic lipids such as unsaturated phosphatidic
acid or phosphatidylserine will exist in bilayers unless the headgroup
charge is neutralized either by low pH or by the presence of multivalent
cations, such as Ca2+. So, PE was chosen for this experiment.
Thus, it is expected that PE containing membranes should be more
sensitive to the action of other fusogenic molecules [31]. In the pre-
sent report SUVs containing PE were used to support fusion as the ac-
tion mechanism of StarD7 expecting that these membranes would be
more prone to follow fusion than SUVPC-PS.
5. Concluding remarks
Curvature stress may be the driving force leading to a reduction in
the surface free energy through membrane fusion. This was reﬂected
in our experiments where labeled SUVs weremixed with LUVs at zero
StarD7 concentration (Fig. 2). StarD7 may serve to screen electrostat-
ic, steric and hydration forces that create a repulsive barrier between
membranes. StarD7may also facilitate close apposition of membranes
and initiate membrane aggregation by lowering the surface charge or
the number of water sites thereby diminishing membrane repulsion.
The efﬁciency of lipid dilution depended on StarD7 electrostatic inter-
action with the lipid–water interface as shown by the pH and salt
modulation (Fig. 4). StarD7 binding to PS containing monomolecular
layers at the air–water interface had been demonstrated previously
[10]. In the present study we showed that, in conditions where electro-
static charges were screened, lipid dilution after LUVs addition was
inhibited both in the presence and in the absence of StarD7 (Fig. 4c).
In the former case this may reﬂect the requirement of protein binding
as a starting stage of the fusion process, while in the later case a reduc-
tion in membrane curvature may stabilize SUVs and may also contrib-
ute to the fusion inhibition (see below).
Most membrane fusion in biological systems (e.g. endocytosis,
exocytosis, intracellular vesicle trafﬁcking, fertilization, virus entry
into the cells, etc.) is induced or mediated by proteins on these mem-
branes, followed by mixing of the membrane lipids. It is assumed that
at some point during fusion a pore is formed with proteinaceous or li-
pidic composition [32]. According to the proteinaceous pore hypoth-
esis, fusion starts with a single proteinaceous channel that later opens
into a full fusion pore due to diffusion of the protein components in
the lipid bilayer [33]. On the other hand, the lipidic pore hypothesis
states that fusion proceeds through a hemifusion event. The latter is
a partially fused structure in which lipids mix although aqueous com-
partments do not and consists of nonlamellar lipid structures such as
HII phase. This is the “stalk model”. Siegel proposed a “modiﬁed stalk
model” in which another type of intermediate structure, the trans-
membrane contact (TMC), might also be energetically possible [30].
It has been shown thatwhen lipidswith positive spontaneous curvature
are incorporated into the low radius curvature membrane, it would re-
duce the surface energy of the positively curved membrane and mem-
brane fusion is suppressed [34–37]. Lipids with positive spontaneous
curvature will lower the energy state of membranes of low radius cur-
vature and at the same time will unstabilize or inhibit the HII phase
[38] which requires lipids with negative curvature. On the contrary,
lipidswith negative spontaneous curvature are expected to favor the fu-
sion process. Accordingly, we found that lipid dilution was favored by
non-lamellar forming lipids such as PE (Fig. 7) and StarD7 further in-
creased the labeled lipid dilution in the presence of PE containingmem-
branes up to a common maximum. This indicated that StarD7 and PE
contributed to lipid dilution through the same mechanism (i.e. mem-
brane fusion). These results in conjunction with the pH and salt sensi-
tivity, as well as the ability of StarD7 to affect the surface pressure and
electrostatics in Langmuir ﬁlms [10] indicated that the protein's surface
433S. Angeletti et al. / Biochimica et Biophysica Acta 1818 (2012) 425–433activity is the main force driving the whole phenomenon which,
through phase changes in bilayers, proceeds toward membrane fusion.
Finally, experiments using vesicles containing PE, as well as FRET,
DLS and cell–cell fusion strongly support fusion as themainmechanism
leading to ﬂuorescence dequenching through labeled lipid dilution
upon StarD7 binding to the lipid–water interface. Present results sug-
gest a possible molecular mechanism and provide experimental sup-
port to our proposal that StarD7 may play an important role in the
phospholipid-mediated signaling of trophoblastic tumor cellular
events, as well as in its effect in promoting membrane fusion in cells.
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